Meiying Zhang

机构：Qingdao University, Fujian Medical University, Shanghai Jiao Tong University, Chinese Academy of Sciences, Beijing Botanical Garden, Renji Hospital, Beijing Forestry University, Qingdao Municipal Hospital, Second Affiliated Hospital of Fujian Medical University, Institute of Botany, China National Botanical Garden · ORCID：0009-0002-9104-7412

发表论文 173 篇 · 总被引 3827 次 · h-index 30

代表论文

• Discovery of LWY713 as a potent and selective FLT3 PROTAC degrader with in vivo activity against acute myeloid leukemia (2023 · European Journal of Medicinal Chemistry · 被引 24)
• Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer. (2024 · PubMed · 被引 17)
• Food-derived peptides as novel therapeutic strategies for NLRP3 inflammasome-related diseases: a systematic review (2023 · Critical Reviews in Food Science and Nutrition · 被引 17)
• Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling (2024 · Cancer Biology & Therapy · 被引 16)
• The involvement of aquaporin 5 in the inflammatory response of primary Sjogren’s syndrome dry eye: potential therapeutic targets exploration (2024 · Frontiers in Medicine · 被引 13)
• Epigenetic silencing schlafen-11 sensitizes esophageal cancer to ATM inhibitor (2024 · World Journal of Gastrointestinal Oncology · 被引 10)